EUVIMEDEUVIMED entdecken
Crossref

Sarcomas With EWSR1::NFATC2 and FUS::NFATC2 Gene Fusions Arising in Soft Tissue and Bone: A Clinicopathologic Study of 32 Cases Emphasizing Their Wide Morphologic and Clinical Spectrum

Jorge Torres-Mora, Carina A Dehner, Laura M Warmke, Andrew L Folpe, John S A Chrisinger, Elizabeth G Demicco, Brendan C Dickson, John M Gross, Justin A Bishop, Sounak Gupta, Darya Buehler, Benjamin Kipp und 7 weitere

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2026.101050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Jorge Torres-Mora und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: torresmora.jorge@mayo.edu. Hauptthemen laut MEDLINE: Sarcoma, Bone Neoplasms, Soft Tissue Neoplasms, RNA-Binding Protein FUS. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone and soft tissue sarcomas harboring EWSR1::NFATC2 and FUS::NFATC2 fusions (NFATC2-rearranged sarcomas) are a recently defined entity with a morphologic spectrum and clinical behavior that are not fully elucidated. We studied 32 such sarcomas that occurred in 21 male and 11 female patients. The EWSR1::NFATC2 fusion was found in tumors of 25 patients (17 men and 8 women; median age, 40 years; range, 14-78 years), 16 of which arose in soft tissue, while 8 originated in the bone. Morphologically, they showed relatively consistent morphologic features yet variable degrees of cytologic atypia, mitotic rates, and necrosis. Follow-up (19 patients; median, 22 months; range, 1-70 months) demonstrated local recurrence in 3 patients, while distant metastases occurred in 6 patients. Two patients died of disease, 4 were alive with disease, and 13 were alive without evidence of disease. In contrast, the FUS::NFATC2 fusion was exclusively seen in osseous tumors, which occurred in 7 patients (4 men and 3 women; median age, 32 years; range, 4-62 years). Further, FUS::NFATC2 tumors showed significant morphologic heterogeneity. Follow-up (6 patients; median, 18 months; range, 13-60 months) demonstrated local recurrence in 2 patients and lung metastases in 2 patients. At the last follow-up, 3 patients were alive with disease, while 3 patients were alive without evidence of disease. Using a 2-tiered grading scheme based on cytologic atypia, mitotic rate, and necrosis, patients with low-grade tumors experienced significantly fewer adverse events than those with high-grade tumors (P = .026); however, estimated metastasis-free survival was not statistically significant due to our limited sample size. Overall, our study expands on the morphologic spectrum of NFATC2-rearranged sarcomas and highlights the clinicopathologic, molecular, and genetic differences between the EWSR1- and FUS-rearranged tumors. Although additional long-term follow-up data are required, our study further suggests that a subset of these sarcomas have a protracted clinical course, while high-grade morphologic features such as atypia, mitotic activity, and necrosis may correlate with worse behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaBone NeoplasmsSoft Tissue NeoplasmsRNA-Binding Protein FUSNFATC Transcription FactorsOncogene Proteins, FusionHumansFemaleAdultMaleAdolescentMiddle AgedYoung AdultAgedRNA-Binding Protein EWSGene FusionIn Situ Hybridization, FluorescenceBiomarkers, Tumor

Stichwörter der Autor:innen

EWSR1FUSNFATC2bonesarcomasoft tissue

Substanzen

RNA-Binding Protein FUSNFATC Transcription FactorsFUS protein, humanRNA-Binding Protein EWSOncogene Proteins, FusionNFATC2 protein, humanEWSR1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: torresmora.jorge@mayo.edu.
  • Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Pathology, Indiana University, Indianapolis, Indiana.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Department of Pathology, Barnes-Jewish Hospital, St. Louis, Missouri.
  • Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada.

Zitieren

APA

Torres-Mora, J., Dehner, C. A., Warmke, L. M., Folpe, A. L., Chrisinger, J. S. A., Demicco, E. G., Dickson, B. C., Gross, J. M., Bishop, J. A., Gupta, S., Buehler, D., Kipp, B., Michal, M., Iding, J. S., Halling, K. C., Wenger, D. E., Pujari, G. P., Alvand, S., & Fritchie, K. J. (2026). Sarcomas With EWSR1::NFATC2 and FUS::NFATC2 Gene Fusions Arising in Soft Tissue and Bone: A Clinicopathologic Study of 32 Cases Emphasizing Their Wide Morphologic and Clinical Spectrum. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101050

Vancouver

Torres-Mora J, Dehner CA, Warmke LM, Folpe AL, Chrisinger JSA, Demicco EG, et al. Sarcomas With EWSR1::NFATC2 and FUS::NFATC2 Gene Fusions Arising in Soft Tissue and Bone: A Clinicopathologic Study of 32 Cases Emphasizing Their Wide Morphologic and Clinical Spectrum. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101050

BibTeX
@article{TorresMora2026,
  author = {Torres-Mora, Jorge and Dehner, Carina A and Warmke, Laura M and Folpe, Andrew L and Chrisinger, John S A and Demicco, Elizabeth G and Dickson, Brendan C and Gross, John M and Bishop, Justin A and Gupta, Sounak and Buehler, Darya and Kipp, Benjamin and Michal, Michael and Iding, Jeffrey Stephen and Halling, Kevin C and Wenger, Doris E and Pujari, Ganesh P and Alvand, Saba and Fritchie, Karen J},
  title = {Sarcomas With EWSR1::NFATC2 and FUS::NFATC2 Gene Fusions Arising in Soft Tissue and Bone: A Clinicopathologic Study of 32 Cases Emphasizing Their Wide Morphologic and Clinical Spectrum},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2026.101050}
}
Kostenlos starten →